Medication used to control blood sugar in people with type 2 diabetes may also reduce the risk of autoimmune diseases
Sunday, October 27, 2013 - 12:30
in Health & Medicine
Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to new research.